“…For PDD, Ps are reported on their ability to solubilize within aqueous media simulating biological fluids, their cellular uptake efficiency and nature thereof (passive versus active), their intracellular localization points for knowledge of the targeted areas, their potential unwanted dark cytotoxicity, their potential to fluoresce following excitation within a given tissue type and their ability to preferentially accumulate within a targeted tissue type . For PDT, analysis encompasses a number of topics including optimization of individual Ps and light excitation dosages that fall within non‐toxic parameters, establishing an efficient dosage combination to achieve a desired percentage of in vitro population damage (the particular cellular trait analysed is chosen at the discretion of the researcher), determining whether the damage inflicted is associated with homoeostatic stress or a photocytotoxic response, confirming the induction of proliferation arrest or cell death due to the PDT conditions, observing various critical biomarkers for identification of the particular cell death mode exhibited by the cells in treatment, and lastly, whether this cell death confers population eradication or resistance to repeated treatment regimes - Recreation for in vivo success: These studies work with live animal models and clinical trials to deduce tissue selectivity of the Ps for maximal accumulation, sufficient solubilization and transport within biological fluids, light irradiation versus tissue depth penetration for both PDD and PDT, induction of secondary body responses to PDT such as immune system stimulation and vascular damage within the aberrant tissue region, detection of any unwanted Ps‐related stress to bystander organ systems and tissues and the comparative analyses of tumour reduction versus eradication against similar treatment regimes.
…”